Sigma Healthcare Limited
SIG
Rangering i aksjer
#1047
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Aksjekurs
$1.95
Markedsverdi
$22.39B
Endring (1 dag)
-0.18%
Endring (1 år)
-1.35%
Land
AU
Handel Sigma Healthcare Limited (SIG)
Kategori
Healthcare
Antall utestående aksjer for Sigma Healthcare Limited (SIG)
Antall utestående aksjer per June 2026: 11.50B
Ifølge Sigma Healthcare Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 11.50B. Ved slutten av January 2024 hadde selskapet 1.02B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Sigma Healthcare Limited (SIG) fra 2001 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 11.50B | 631.89% |
| 2025 | 1.57B | 53.41% |
| 2024 | 1.02B | 0.23% |
| 2023 | 1.02B | 0.19% |
| 2022 | 1.02B | 0.28% |
| 2021 | 1.02B | 0.65% |
| 2020 | 1.01B | -0.29% |
| 2019 | 1.01B | -2.47% |
| 2018 | 1.04B | -2.36% |
| 2017 | 1.06B | 0.68% |
| 2016 | 1.06B | -3.75% |
| 2015 | 1.10B | 2.07% |
| 2014 | 1.08B | -31.47% |
| 2013 | 1.57B | 31.42% |
| 2012 | 1.20B | -0.31% |
| 2011 | 1.20B | 21.66% |
| 2010 | 985.46M | -37.25% |
| 2009 | 1.57B | 0.00% |
| 2008 | 1.57B | 0.00% |
| 2007 | 1.57B | 0.00% |
| 2006 | 1.57B | 0.00% |
| 2004 | 1.57B | 0.00% |
| 2003 | 1.57B | 0.00% |
| 2002 | 1.57B | 0.00% |
| 2001 | 1.57B | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 118.70M | -98.97% |
US
|
|
| - | - |
US
|
|
| 236.00M | -97.95% |
US
|
|
| - | - |
US
|
|
| 113.45M | -99.01% |
US
|
